Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CA 125: the past and the future.

R C Bast1, F J Xu, Y H Yu

  • 1Division of Medicine, University of Texas M.D. Anderson Cancer Center, Houston, USA.

The International Journal of Biological Markers
|May 6, 1999
PubMed
Summary

The CA 125 assay is valuable for monitoring ovarian cancer and aiding in early detection. Further research into novel markers and algorithms may improve diagnostic sensitivity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A China-centered framework for assessment of imported emerging infections and implications for cross-national capacity building].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2026
Same author

[Wound repair strategies of natural polysaccharide hydrogels based on microenvironmental regulation].

Zhonghua shao shang yu chuang mian xiu fu za zhi·2025
Same author

[Performance of hyaluronic acid biogel and its effect on healing of infected burn wounds in mice].

Zhonghua shao shang yu chuang mian xiu fu za zhi·2025
Same author

[Research progress on physical activity of childhood cancer survivors].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2024
Same author

MiniBooNE and MicroBooNE Combined Fit to a 3+1 Sterile Neutrino Scenario.

Physical review letters·2022
Same author

Improved light extraction efficiency of AlGaN deep-ultraviolet light emitting diodes combining Ag-nanodots/Al reflective electrode with highly transparent p-type layer.

Optics express·2021

Area of Science:

  • Biochemistry
  • Oncology
  • Clinical Diagnostics

Background:

  • The CA 125 assay, utilizing the OC 125 antibody, has been extensively studied for 15 years.
  • While the gene for CA 125 remains un-cloned, improved assays like CA 125-II offer reduced variability.
  • Elevated CA 125 levels are observed in various benign conditions and multiple cancers, notably epithelial ovarian cancer.

Purpose of the Study:

  • To review the advancements, applications, and limitations of the CA 125 assay in clinical practice.
  • To explore the role of CA 125 in monitoring ovarian cancer treatment response and predicting recurrence.
  • To discuss the potential of CA 125 in early ovarian cancer detection and the development of new diagnostic strategies.

Main Methods:

  • Review of over 2000 laboratory and clinical studies on the CA 125 assay.

Related Experiment Videos

  • Analysis of CA 125's utility in monitoring chemotherapy, surgical surveillance, and distinguishing malignant from benign pelvic masses.
  • Evaluation of risk of ovarian cancer (ROC) algorithms and future directions in biomarker discovery.

    • Main Results:

    • CA 125 decline during chemotherapy is a prognostic factor; persistent elevation predicts residual disease.
    • Rising CA 125 levels often precede clinical detection of recurrence and indicate progressive disease during treatment.
    • The ROC algorithm shows promise for early detection, though sensitivity for early-stage disease requires optimization.

    Conclusions:

    • The CA 125 assay is a well-established tool for ovarian cancer monitoring and has potential in early detection strategies.
    • Future improvements in sensitivity may involve multi-marker approaches and advanced analytical techniques.
    • Exploration of novel markers, including lipids and those identified through genomics/proteomics, is crucial for advancing cancer diagnostics.